The challenge of eliminating cervical cancer in the United States: A story of politics, prudishness, and prevention

Women and Health

Volumn 49, Issue 2-3, 2009, Pages 246-261

  Fisher, Joslyn W ^a   Brundage, Susan I ^b  

^a BEN TAUB GENERAL HOSPITAL   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

HPV vaccine; Pap smear; Policy; Women's health

Indexed keywords

VIRUS VACCINE; WART VIRUS VACCINE;

ARTICLE; CANCER DIAGNOSIS; FEMALE; HEALTH CARE POLICY; HISTORY; HUMAN; INCIDENCE; MASS SCREENING; POLICY; PRECANCER; PREVENTIVE HEALTH SERVICE; SOCIAL PSYCHOLOGY; UNITED STATES; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

EARLY DETECTION OF CANCER; FEMALE; HEALTH POLICY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRECANCEROUS CONDITIONS; PUBLIC POLICY; SOCIAL VALUES; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL VACCINES;

EID: 68049143056     PISSN: 03630242     EISSN: 15410331     Source Type: Journal    
DOI: 10.1080/03630240902915101     Document Type: Article

References (85)

1. Adams, S. H. 1913, May. What can we do about cancer? Ladies Home Journal 21-22.
2. AHCPR. 1999. Evaluation of cervical cytology. Technology Assessment. Rockville, MD: Agency for Health Care Policy and Research.
3. American Cancer Society. 2008. Cancer Facts and Figures. Retrieved September 25, 2008, from http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf
4. American College of Obstetricians and Gynecologists. 1975. The frequency with which a cervical-vaginal cytology examination should be performed in gynecologic practice. Technical Bulletin No. 29. Chicago, IL: ACOG.
5. Ayre, J. E. 1947. Selective cytology smear for diagnosis of cancer. Am J Obstet Gynecol 53:609-17.
6. Baden, L. R., G. D. Curfman, S. Morrissey, and J. M. Drazen. 2007. Human papillomavirus vaccine-opportunity and challenge. N Engl J Med 356:1990-1.
7. Berger, D. 1999. A brief history of medical diagnosis and birth of the clinical laboratory. Part 2. Med Lab Observer 31:32-4, 36, 38.
8. Borgmeyer, C. 2007. Many States are Moving to Require HPV Vaccination for School Entry; AAFP Calls Such Mandates 'Premature' [Electronic Version]. AAFP News Now. Retrieved February 21, 2007, from http://www.aafp.org/online/en/home/publications/news/news-now/clinical-care-research/20070214hpvvaccine.printerview.html
9. Bosch, F. X., A. N. Burchell, M. Schiffman, A. R. Giuliano, S. de Sanjose, L. Bruni, G. Tortolero-Luna, S. K. Kjaer, and N. Muñoz. 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 265:K1-16.
10. Bryans, F. E., D. A. Boyes, and H. K. Fidler. 1964. The influence of a cytological screening program upon the incidence of invasive squamous cell carcinoma of the cervix in British Columbia. Am J Obstet Gynecol 88:898-906.
11. Burns, E. L., E. C. Hammond, C. Percy, H. Seidman, and T.W. Gorski. 1968. Detection of uterine cancer: results of a community program of 17 years. Cancer Detect Prev 22:1108-19.
12. Cantor, D. 2007. Uncertain enthusiasm: The American Cancer Society, public education, and the problems of the Moview, 1921-1960. Bull Hist Med 81:39-69.
13. Carmichael, D. E. 1973. The Pap Smear, pp. 59-61. Springield, Illinois: Charles C. Thomas.
14. CDC. 2006. HPV and HPV Vaccine: Information for Healthcare Providers. [Electronic Version] from http://www.cdc.gov/std/HPV/hpv-vacc-hcp-3-pages.pdf
15. Childe, C. P. 1925. What the public should know about the prevention of cancer. In Cancer and the Public, pp. 199-200. New York: EP Dutton & Company, Inc.
16. Colgrove, J. 2006. The ethics and politics of compulsory HPV vaccination. N Engl J Med 355:2389-91.
17. Crossen, H. S. 1933. Prevention of cancer of the cervix uteri. Am J Ob Gyn 26:686-95.
18. Dempsey, A. F., G. D. Zimet, R. L. Davis, and L. Koutsky. 2006. Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics 117:1486-93.
19. Dunne, E. F., E. R. Unger, M. Sternberg, G. McGuillan, D. C. Swan, S. S. Patel, and L. E. Markowitz. 2007. Prevalence of HPV infection among females in the U.S. JAMA 297:813-9.
20. Elliott, J. 2007. Panel votes to block HPV vaccine requirement. Houston Chronicle, February 22, 2007.
21. Erickson, C. C. 1955. Exfoliative cytology in mass screening for uterine cancer: Memphis and Shelby County, Tennessee. CA Cancer J Clin 5:63-4.
22. Fitzpatrick, G. 1927. How shall we deal with the cancer menace? Am J Ob Gyn 14:616-26.
23. Frazer, I. H., J. T. Cox, E. J. Mayeaux, E. L. Franco, A. B. Moscicki, J. M. Palefsky, D. G. Ferris, A. S. Ferenczy, and L. L. Villa. 2006. Advances in prevention of cervical cancer and other human papillomavirus-related diseases. Pediatr Infect Dis J 25:365-81.
24. Friedman, L. S., J. Kahn, A. B. Middleman, S. L. Rosenthal, G. D. Zimet, and Society for Adolescent Medicine. 2006. Human papillomavirus (HPV) vaccine: A position statement of the Society for Adolescent Medicine. J Adolesc Health 39:620.
25. Future II Study Group. 2007. Quadrivalent vaccine against HPV to prevent high grade cervical lesions. N Engl J Med 356:1915-27.
26. Gardner, K. 2006. Early detection: Women, cancer and awareness campaigns in the twentieth century U.S. North Carolina: UNC Press.
27. Harlan, L. C., A. B. Bernstein, and L. G. Kessler. 1991. Cervical cancer screening: Who is not screened and why? Am J Public Health 81:885-90.
28. Hellman, L. M. 1969. The oral contraceptives in clinical practice. Family Planning Perspectives 1:13-7.
29. Hewitt, M., S. S. Devesa, and N. Breen. 2004. Cervical cancer screening among U.S. women: Analyses of the 2000 National Health Interview Survey. Prev Med 39:270-8.
30. Ho, G. Y. F., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-8.
31. Holmquist, N. D. 1990. The delayed diagnosis of invasive carcinoma of the uterine cervix. J La State Med Soc 142:37-9.
32. Jain, N., S. Stokley, and D. Yankey. 2009. Vaccination coverage among adolescents aged 13-17 years-United States, 2007. MMWR 57:1100-03.
33. Katz, S. J., and T. P. Hofer. 1994. Socioeconomic disparities in preventive care persist despite universal coverage. JAMA 272:530-4.
34. Kaufman, M. 2006. FDA approves vaccine that should prevent most cervical cancers. Washington Post, June 9, 2006.
35. Kelso, J. W., and J. W. Funnell. 1963. Office cytology. CA Cancer J Clin 13:180-2.
36. Kim, J. J., and S. J. Goldie. 2008. Health and economic implications of HPV vaccination in the United States. N Engl J Med 359:821-32.
37. Koss, L. G. 2003. Letter to the Editor (Re: Aural Babes). Int Journal of Gyn Path 22:101-2.
38. Kuehn, B. M. 2006. CDC panel backs routine HPV vaccination. JAMA 296:640-1.
39. Kulasingam, S. L., and E. R. Myers. 2003. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 290:781-9.
40. Lawson, H. W., R. Henson, J. K. Bobo, and M. K. Kaeser. 2000. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR 49:35-55.
41. Lerner, B. H. 2000. The illness and death of Eva Peron: Cancer, politics, and secrecy. Lancet 355:1988-91.
42. Macfarlane, C., M. C. Sturgis, and F. Fetterman. 1953. Periodic examination of the female pelvic organs and breasts: Report of a fifteen-year research on the control of cancer. CA Cancer J Clin 3:205-7.
43. Monk, B. J., and D. J. Wiley. 2006. Will widespread human papillomavirus prophylactic vaccination change sexual practices of adolescent and young adult women in America? Obstet Gynecol 108:420-4.
44. Morabia, A., and F. F. Zhang. 2004. History of medical screening: From concepts to action. Postgrad Med J 80:463-9.
45. Nobbenhuis, M. A., J. M. Walboomer, T. J. Helmerhorst, L. Rozendaal, A. J. Remmink, E. K. Risse, H. C. van der Linden, E. J. Voorhorst, P. Kenemans, and C. J. Meijer. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study. Lancet 354:20-5.
46. Oken, D. 1961. What to tell cancer patients. A study of medical attitudes. JAMA 175:1120-8.
47. Papanicolaou, G. N., and H. F. Traut. 1941. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Ob Gyn 42:193-206.
48. Parker, S. L., T. Tong, S. Bolden, and P. A. Wango. 1996. Cancer statistics. CA Cancer J Clin 65:5-27.
49. Patterson, J. T. 1987. The Dread Disease: Cancer and Modern American Culture. Cambridge: Harvard University Press.
50. Raffle, A. E. 2007. Human papillomavirus vaccine policy. The Lancet 369:367-8.
51. Reagan, L. J. 1997. Engendering the dread disease: Women, men, and cancer. Am J Public Health 87:1779-87.
52. Ross, J. 1970. The pill hearings: Major side effects. Family Plan Perspec 2:6-7.
53. Ross, W. S. 1987. Crusade: The Official History of the American Cancer Society, pp. 18-19, 76-93. New York, NY, USA: Arbor House Publishing Company.
54. Ryerson, A. B., V. B. Benard, and A. C. Major. 2005. National Breast and Cervical Cancer Early Detection Program: National Report 1991-2002. Atlanta, GA: Centers for Disease Control and Prevention.
55. Saslow, D., P. E. Castle, J. T. Cox, D. D. Davey, M. H. Einstein, D. G. Ferris, S. J. Goldie, et al. 2007. American Cancer Society Guideline for HPV vaccine use to prevent cervical cancer and it's precursors. CA Cancer J Clin 57:7-28.
56. Sawaya, G. F., A. D. Brown, A. E. Washington, and A. M. Garber. 2001. Current approaches to cervical-cancer screening. NEJM 344:1603-7.
57. Schiff M. A., R. J. Apple, P. Lin, J. L. Nelson, C. M. Wheeler, and T. M. Becker. 2005. HLA alleles and risk of cervical intraepithelial neoplasia among Southwestern American Indian women. Human Immunology 66:1050-6.
58. Schmitz, H. 1932. The correlation between the development of the growth and the symptoms of carcinomas of the uterine cervix. Am J Ob Gyn 23:159.
59. Schwartz, J. L., A. L. Caplan, R. R. Faden, and J. Sugarman. 2007. Lessons from the failure of human papillomavirus vaccine state requirements. Nature: Clinical Pharmacology & Therapeutics 82:760-3.
60. Shavers, V. L., and M. L. Brown. 2002. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94:334-57.
61. Shefer, A., L. Markowitz, S. Deeks, T. Tam, K. Irwin, S. M. Garland, and A. Schuchat. 2008. Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine 265:K68-75.
62. Shimkin, M. B. 1977. As memory serves-an informal history of the National Cancer Institute, 1937-1957. J Natl Cancer Inst 59:589.
63. Shultz, G. D. 1955, April. Women need no longer die of their No. 1 cancer foe. Ladies Home Journal 61-2, 164-6.
64. Singh, G. K., B. A. Miller, B. K. Hankey, and B. F. Edwards. 2004. Persistent area socioeconomic disparities in the US: Incidence of cervical cancer, mortality, stage, and survival 1975-2000. Cancer 101:1051-7.
65. Smith, G. V., R. H. Smithwick, and H. Rogers. 1928. A report of cases of carcinoma of the cervix treated between 1875 and 1927 at the Boston Free Hospital for Women. Am J Ob Gyn 15:637-50.
66. Spector, M. 2006. The Bush Administration's war on the laboratory. The New Yorker, March 13, 2006, pp. 57-69.
67. Stewart, A. M. 2007. Mandating HPV vaccination-private rights, public good. N Engl J Med 356:1998-9.
68. Sung, J. F., E. Alema-Mensah, and D. S. Blumenthal. 2002. Inner-city African American women who failed to receive cancer screening following a culturallyappropriate intervention: The role of health insurance. Cancer Detect Prev 26:28-32.
69. Tsui, J., M. Saraiya, T. Thompson, A. Dey, and L. Richardson. 2007. Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J Women's Health 16:1447-57.
70. Unlisted. 1947. Doubt on Vaginal Smear. Newsweek, November 17, 1947, p. 52.
71. Unlisted. 1957. The American Cancer Society and Cervical Cancer. Cancer News (Winter), pp. 2-9.
72. Unlisted. 1961. ACS launches campaign to conquer uterine cancer. Cancer News, 15(Spring).
73. Unlisted. 1973. George Nicholas Papanicolaou (1883-1962). CA Cancer J Clin, 23: 171-3.
74. U.S. Cancer Statistics Working Group. 2005. United States Cancer Statistics: 1999-2002 Incidence and Mortality Web-based Report Version. [Electronic Version] from http://www.cdc.gov/cancer/npcr/uscs
75. U.S. Department of Health and Human Services Office of Women's Health. 2008. Quick Health Data Online. Retrieved September 26, 2008, from www.4women.gov
76. Villa, L. L., R. L. Costa, A. Petta, R. P. Andrade, K. A. Ault, A. R. Giuliano, C. M. Wheeler, et al. 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6:271-8.
77. Vilos, G. A. 1998. The history of the Papanicolaou smear and the odyssey of George and Andromache Papanicolaou. Obstet Gynecol 91:479-83.
78. Ward, E., A. Jemal, V. Cokkinides, G. K. Singh, C. Cardinez, A. Ghafoor, and M. Thun. 2004. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54:78-93.
79. Weinstock, H., S. Berman, and W. J. Cates. 2004. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 36:6-10.
80. Weisberg, S., and D. Castellan. 2007. Health Issues: Human Papilloma Virus Vaccination Position Statement [Electronic Version]. American College of Pediatricians website. Retrieved February 21, 2007, from http://acpeds.org
81. Women in Government. 2007.Women in Government Position Statement on Cervical Cancer Prevention. Retrieved February 21, 2007, from http://www.womeningovernment.org/prevention/documents/womeningovtpositionstatementonccprevention.pdf
82. Women in Government. 2009. A Roadmap for Success: The state of cervical cancer prevention in America 2009. Retrieved February 16, 2009, from http://www.womeningovernment.org/files/file/prevention/statereports/2009/wig2009.pdf
83. Wood, S. F. 2005. Women's health and the FDA. N Engl J Med 353:650-1.
84. Yaremchuk, W. A. 1977. The origins of the National Cancer Institute. J Natil Cancer Inst 59:551-8.
85. zur Hausen, H. 2009. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384:360-5.